Nirva Contraindications



Amherst Lab


Full Prescribing Info
Known hypersensitivity to clozapine or any ingredient of the product; In patients with myeloproliferative disorders, uncontrolled epilepsy, paralytic ileus, or a history of clozapine-induced agranulocytosis or severe granulocytopenia.
In patients who are unable to undergo regular blood tests.
History of toxic or idiosyncratic granulocytopenia/agranulocytosis (with the exception of granulocytopenia/agranulocytosis from previous chemotherapy).
Impaired bone marrow function.
Alcoholic and other toxic psychoses, drug intoxication, comatose conditions.
Circulatory collapse and/or CNS depression of any cause; Severe renal or cardiac disorders (e.g., myocarditis).
Active liver disease associated with nausea, anorexia or jaundice; progressive liver disease, hepatic failure.
Concomitant use with long-acting depot antipsychotics (which have myelosuppressive potential) since these cannot be rapidly removed from the body in situations where this may be required (e.g., Neutropenia). (See Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in